TNFSF11 and osteoporosis: The suppression of ROS could be effective in inhibiting RANKL-induced osteoclastogenesis given that RANKL activates MAPK and NF-κB, causing ROS to enhance osteoclastogenesis and associate with the pathogenesis of osteoporosis [34, 45].